DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Kim JB, Lee M, Park SY. et al.
Sorafenib inhibits cancer side population cells by targeting c‑Jun N‑terminal kinase signaling.
Mol Med Rep 2015;
12 (06) 8247-8252
We do not assume any responsibility for the contents of the web pages of other providers.